# Ezetimibe Versus Nutraceuticals in Statin-intolerant Patients

> **NCT01490229** · PHASE4 · UNKNOWN · sponsor: **University of Roma La Sapienza** · enrollment: 100 (estimated)

## Conditions studied

- Coronary Artery Disease

## Interventions

- **DRUG:** Ezetimibe
- **DRUG:** Nutraceuticals

## Key facts

- **NCT ID:** NCT01490229
- **Lead sponsor:** University of Roma La Sapienza
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2013-01
- **Primary completion:** 2014-12
- **Final completion:** 2016-12
- **Target enrollment:** 100 (ESTIMATED)
- **Last updated:** 2013-03-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01490229

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01490229, "Ezetimibe Versus Nutraceuticals in Statin-intolerant Patients". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT01490229. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*